Lepu Scientech Reports 32.4% Increase in Revenue and 29.8% Rise in Net Profit for H1 2025
I'm PortAI, I can summarize articles.
Lepu Scientech Medical Technology Shanghai Co. Ltd. reported a 32.4% increase in revenue for H1 2025, reaching RMB 329.7 million, and a 29.8% rise in net profit to RMB 182.0 million. Despite these gains, the Board will not recommend an interim dividend, consistent with the previous year. The company focuses on developing heart disease interventional medical devices, leveraging over 20 years of industry experience.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments